Apixaban is an oral anticoagulant prescribed to prevent blood clots and lower stroke risk. Being familiar with its long‑term side effects, potential drug interactions, contraindications, and monitoring needs helps clinicians and patients make informed choices and manage bleeding risks and other complications.
Common and Rare Long‑Term Side Effects of Apixaban
The main long‑term risk with apixaban is bleeding, which can range from minor bruising to major hemorrhage. Less common adverse effects include neurological symptoms that require prompt evaluation. Early recognition of warning signs allows timely treatment.
Long‑term extension studies show sustained safety and effectiveness for apixaban, with relatively low rates of serious adverse events reported.
Apixaban Long‑Term Safety: Stroke & Major Bleeding Rates In the open‑label extension, annual rates of stroke or systemic embolism, hemorrhagic stroke, and major bleeding were similar to those seen during apixaban treatment in AVERROES. These results support apixaban's long‑term efficacy and safety in people with atrial fibrillation. Long-term treatment with apixaban in patients with atrial fibrillation: outcomes during the open-label extension following AVERROES, AP Benz, 2021
Which bleeding risks are associated with prolonged Apixaban use?
Long‑term apixaban use raises bleeding risk. Watch for these signs of major bleeding:
New or unexplained bruising: May signal internal bleeding.
Blood in urine or stool: Hematuria or melena can indicate significant blood loss.
Severe or sudden headache, fainting, or dizziness: May suggest intracranial bleeding.
Seek immediate medical attention for these symptoms — prompt care reduces the chance of serious harm.
Are there other significant side effects to monitor during long-term therapy?
Monitor kidney and liver function because apixaban is partly cleared by the kidneys and processed by the liver. Other issues to watch for include:
Fatigue: Could reflect complications or other medical issues.
Nausea or gastrointestinal discomfort: May affect adherence to treatment.
Skin reactions: Rash or allergic responses can occur in some patients.
Regular follow‑up and clear patient–provider communication help manage these concerns effectively.
How Does Apixaban Interact with Other Medications and What Are the Contraindications?
Understanding apixaban's drug interactions can reduce bleeding risk. Certain medicines change apixaban levels and require careful management.
What drug interactions increase bleeding or adverse effects risk?
Agents that raise bleeding risk or increase apixaban exposure include:
Other anticoagulants: e.g., warfarin or rivaroxaban — combining agents increases bleeding risk.
Nonsteroidal anti‑inflammatory drugs (NSAIDs): Such as ibuprofen or naproxen — increase gastrointestinal bleeding risk.
Certain antibiotics and antifungals: May affect apixaban metabolism and raise plasma concentrations.
Tell your prescriber about all prescription, over‑the‑counter, and complementary medicines so potential interactions can be identified and managed.
Which patient conditions contraindicate Apixaban use?
Clinical contraindications include:
Active bleeding disorders: For example, hemophilia.
Severe renal impairment: Leads to higher drug exposure and increased bleeding risk.
Significant liver disease: Impaired metabolism raises the risk of adverse effects.
Assess comorbidities and relevant laboratory tests before starting—and during—therapy to help ensure safety.
What Are the Recommended Patient Monitoring and Safety Measures for Long-Term Apixaban Use?
A structured monitoring program reduces risk and maximizes benefit during long‑term apixaban therapy.
How should bleeding risks be managed and detected early?
Manage bleeding risk with a proactive approach that includes:
Regular check‑ups: Routine appointments to review status and any new symptoms.
Patient education: Clear guidance on bleeding signs and when to seek care.
Emergency protocols: Instructions for what to do after injuries or if bleeding occurs.
These steps reduce the likelihood of severe complications.
What clinical tests and follow-up schedules optimize safety?
Recommended evaluations include routine blood tests to monitor renal and hepatic function, follow‑up visits every 3–6 months, and periodic checks on adherence and dosing to confirm correct use.
Following these protocols supports safe, effective long‑term treatment.
How Does Apixaban’s Safety Profile Compare with Other Anticoagulants?
Comparing apixaban with other anticoagulants helps choose the right option for each patient.
What are the advantages and disadvantages relative to similar drugs?
Advantages of apixaban versus some traditional agents:
Lower risk of major bleeding: Clinical trials have shown reduced rates of severe bleeding compared with warfarin.
No routine monitoring required: Fewer regular blood tests than with warfarin.
Rapid onset of action: Provides quicker anticoagulation in acute settings.
Clinical trial data further support apixaban's favorable profile regarding major bleeding incidence.
Apixaban's Lower Major Bleeding Risk: ARISTOTLE Data A reanalysis of ARISTOTLE data suggested that apixaban is associated with a reduced risk of major bleeding regardless of dose adjustments in higher‑risk patients. Major bleeding risk during anticoagulation with warfarin, dabigatran, apixaban, or rivaroxaban in patients with nonvalvular atrial fibrillation, G Adeboyeje, 2017
Potential disadvantages:
Cost: Apixaban may be more expensive than some older anticoagulants.
Reversal agent availability: Antidotes exist but may not be universally accessible.
How do side effect frequencies differ among anticoagulants?
Event rates vary; for example, apixaban often shows a lower gastrointestinal bleeding rate than warfarin. Choose therapy based on an individualized risk–benefit assessment.
Different side effects associated with Apixaban and other anticoagulants can be summarized in the following table:
Anticoagulant | Common Side Effects | Rare Side Effects | Bleeding Risk |
Apixaban | Bruising, fatigue | Neurological symptoms | Lower than warfarin |
Warfarin | Bruising, nausea | Skin necrosis | Higher than Apixaban |
Rivaroxaban | Bruising, dizziness | Liver enzyme elevation | Similar to Apixaban |
This comparison highlights the importance of choosing an anticoagulant based on individual patient characteristics and likely side effects.
To reduce medication‑related risks, follow recommended dose schedules and seek personalized guidance from your healthcare team.
Frequently Asked Questions
What should I do if I experience side effects while taking Apixaban?
Contact your healthcare provider promptly. They will assess your symptoms and determine whether a dose adjustment or a different anticoagulant is needed. Note when symptoms started and how they developed to help the evaluation.
Can I take over-the-counter medications while on Apixaban?
Some OTC medicines—especially NSAIDs like ibuprofen and naproxen—raise bleeding risk. Always check with your clinician before starting any new OTC or herbal product.
How long does it take for Apixaban to start working?
Apixaban starts working within hours and usually reaches peak effect at about 3–4 hours. Take it exactly as prescribed.
Are there dietary restrictions while taking Apixaban?
Unlike warfarin, apixaban doesn't require vitamin K restrictions. Still avoid heavy alcohol use and talk with your clinician about any major dietary changes.
What should I do if I miss a dose of Apixaban?
If you miss a dose, take it as soon as you remember that day. If the next dose is due soon, skip the missed dose—do not double up. Check with your provider if you're unsure.
How often should I have follow-up appointments while on Apixaban?
Routine follow‑up every 3–6 months is typical for long‑term therapy, or sooner if advised by your clinician, to monitor kidney and liver function, effectiveness, and any side effects.
Is there a reversal agent for Apixaban in case of bleeding emergencies?
Andexanet alfa can reverse life‑threatening apixaban‑related bleeding, although availability varies. Always tell healthcare staff you are taking apixaban before procedures or in an emergency.
CIPA-Certified Canadian Pharmacies Provide Safe, Effective Prescription Drugs https://drugmart.com/ is a CIPA-member Canadian prescription referral service with hundreds of medications at incredible savings. We source from reputable pharmacies located in the United Kingdom, New Zealand, Australia and Canada. We offer non-prescription Canada drugs and pet medications, too!
Sources
Mayall, S., Kahlon, R., Al‐Dakkak, I., & Shen, S. (2021). Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe. Pharmaceutical Medicine, 35(2), 123-135. https://link.springer.com/article/10.1007/s40290-021-00380-1
Foletti, M., Schmutz, T., Fleury, Y., Magnin, J., Terrier, C., & Guéchi, Y. (2023). Bleeding on oral anticoagulants: overview of reversal strategies. Swiss Medical Weekly, 153(2), 40036. https://smw.ch/index.php/smw/article/view/3297
Osasu, Y., Cooper, R., & Mitchell, C. (2021). Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis. BMC Family Practice, 22(1). https://link.springer.com/article/10.1186/s12875-021-01590-x
Related Articles
Importing Prescription Drugs for Personal Use: Is the Importation of Drugs from Canada Safe?
Talk about the importation of drugs is frequently in the news. But what does that mean for Americans? Is importing prescription drugs for personal use legal?...
Apixaban: Common Side Effects — Clear Overview and Safety Guidance
Apixaban is an oral anticoagulant used to reduce stroke risk in atrial fibrillation and to treat and prevent venous thromboembolism. It lowers the chance of clot formation but can...
CIPA: How Online Canadian Pharmacies Save You Money
The Canadian International Pharmacy Association (CIPA) was formed in 2002. Their job is to work with regulators, pharmacists, physicians, consumer special interest groups, government members and...
